prosidyan
-
Biologics
Prosidyan® FIBERGRAFT® Achieves High Fusion Rate in Multi-Center Clinical Study Presented at Top Neurosurgery Conference
FIBERGRAFT® BG Matrix Achieved 96.3% Fusion Rate in Posterolateral Spine Fusion Clinical Study NEW PROVIDENCE, N.J. (PRWEB) AUGUST 26, 2021 Prosidyan,…
Read More » -
Biologics
Prosidyan® Receives CE Mark for FIBERGRAFT® BG Family of Products
FIBERGRAFT® BG Putty, FIBERGRAFT® BG Putty GPS, FIBERGRAFT® BG Morsels for use in the Lumbar Spine and Anterior Cervical Spine…
Read More » -
Biologics
DePuy Synthes Announces Agreement with Prosidyan to Exclusively Promote FIBERGRAFT® Family of Products for Spine Fusion Surgery
RAYNHAM, Mass. – May 9, 2018 – DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announced an…
Read More » -
Biologics
Prosidyan Announces FDA Clearance and Commercial Launch of Its FIBERGRAFT BG MATRIX for Poster-Lateral Spinal Fusion
Warren, NJ, October 26, 2017 –(PR.com)– NJ-based Prosidyan (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today FDA 510(k)…
Read More » -
Biologics
OrthoSpineNews Interview with Charanpreet Bagga, Prosidyan’s President and CEO and Renowned Surgeon Dr. Hyun Bae
At OrthoSpineNews, we enjoy attending all the conferences and learning about new technology. There aren’t many areas in orthopedics and…
Read More » -
Hospitals
Prosidyan Receives FDA Clearance of Its FIBERGRAFT BG Putty for Postero-Lateral Spinal Fusion
Warren, NJ, June 01, 2017 –(PR.com)– NJ-based Prosidyan (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it…
Read More » -
Biologics
Prosidyan Announces an Exclusive Joint Collaboration and License Agreement with MO-SCI Corporation for an Exciting New Technology
Warren, NJ, June 30, 2016 –(PR.com)– New Jersey based company Prosidyan, Inc. (www.prosidyan.com), developer of proprietary fiber-based bioactive glass orthobiologics…
Read More » -
Hospitals
Prosidyan Announces FDA 510(k) Clearance of FIBERGRAFT BG Morsels for Postero-Lateral Spinal Fusion
Warren, NJ, November 16, 2015 –(PR.com)– NJ-based Prosidyan (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it…
Read More » -
Biologics
Prosidyan™ Announces FDA 510(k) Clearance of FIBERGRAFT™BG Putty – Bone Graft Substitute
Warren, NJ, March 26, 2015 –(PR.com)– NJ-based Prosidyan™ (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it…
Read More »